CAMBRIDGE, England–(BUSINESS WIRE)–Crescendo Biologics Limited, the drug discovery and developer of Humabody® therapeutics, has been granted U.S. patent No. 9,439,405 to its novel transgenic mouse platform (Crescendo Mouse)